Currently out of the existing stock ratings of Caroline Palomeque, 3 are a BUY (75%), 1 are a HOLD (25%).

Caroline Palomeque

Work Performance Price Targets & Ratings Chart

Analyst Caroline Palomeque, currently employed carries an average stock price target met ratio of 75% that have a potential upside of 133.16% achieved within 782 days.

Caroline Palomeque’s has documented 7 price targets and ratings displayed on 2 stocks. The coverage was on the Healthcare sector.

Most recent stock forecast was given on DARE, Dare Bioscience at 14-Aug-2024.

Wall Street Analyst Caroline Palomeque

Analyst best performing recommendations are on DARE (DARE BIOSCIENCE).
The best stock recommendation documented was for AVXL (ANAVEX LIFE SCIENCES CORP) at 5/16/2018. The price target of $7 was fulfilled within 904 days with a profit of $4.56 (186.89%) receiving and performance score of 2.07.

Average potential price target upside

AVXL Anavex Life Sciences Corp DARE Dare Bioscience

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$40

$32.55 (436.91%)

$40

18 days ago
(04-Nov-2024)

4/13 (30.77%)

$32.7 (447.95%)

155

Buy

$46

$38.55 (517.45%)

$46

22 days ago
(31-Oct-2024)

6/10 (60%)

$39.38 (594.86%)

1278

Buy

$28

$20.55 (275.84%)

$35

1 years 9 months 13 days ago
(09-Feb-2023)

0/2 (0%)

$17.59 (168.97%)

Hold

$11

$3.55 (47.65%)

$16

1 years 11 months 16 days ago
(06-Dec-2022)

4/7 (57.14%)

$2.62 (31.26%)

134

Buy

$40

$32.55 (436.91%)

$7

2 years 4 months 30 days ago
(23-Jun-2022)

1/2 (50%)

$29.55 (282.78%)

904

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

Which stock is Caroline Palomeque is most bullish on?

Potential upside of $0 has been obtained for DARE (DARE BIOSCIENCE)

What Year was the first public recommendation made by Caroline Palomeque?

On 2018

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?